HERA RAHMAN: Open Payments
NPI 1821611609 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,686 in 144 payments from 35 companies in 2025. Trend: 2023 $1,214 · 2024 $3,163 · 2025 $3,686
Food & beverage: $3,649Education: $37
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 17 | $504 |
| Lilly USA, LLC | 22 | $459 |
| Dexcom, Inc. | 9 | $439 |
| Neurocrine BioSciences, Inc. | 9 | $295 |
| Ascensia Diabetes Care Us Inc. | 9 | $183 |
| Alexion Pharmaceuticals, Inc. | 6 | $175 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $158 |
| Novartis Pharmaceuticals Corporation | 5 | $131 |
| Novo Nordisk Inc | 5 | $124 |
| Madrigal Pharmaceuticals | 3 | $112 |
Products named: Korlym, Dexcom G6 Transmitter, CRENESSITY, MOUNJARO, JARDIANCE, STRENSIQ, Kerendia, LEQVIO.
Industry payments across GA — which companies pay providers there.
